René C-Gaudreault
- Formation
- à venir
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Oncologie
- Adresse
- 10, rue de l'Espinay, E0-171
Québec (Québec)
CANADA G1L 3L5 - Téléphone
- +1 418-525-4444, poste 52363
- Télécopieur
- +1 418-525-4372
- Courriel
- Rene.C-Gaudreault@crsfa.ulaval.ca
Publications récentes (voir toutes les publications de ce chercheur)
Charest-Morin X, Fortin S, Lodge R, Roy C, Gera L, C-Gaudreault R, Marceau F. Inhibitory effects of cytoskeleton disrupting drugs and GDP-locked Rab mutants on bradykinin B receptor cycling. Pharmacological research : the official journal of the Italian Pharmacological Society,
2013. Epub
Fournier MJ, Coudert L, Mellaoui S, Adjibade P, Gareau C, Cote MF, Sonenberg N, Gaudreault RC, Mazroui R. Inactivation of the mTORC1-eIF4E Pathway alters Stress Granules Formation. Molecular and cellular biology,
2013. Epub
Marceau F, Bawolak MT, Lodge R, Bouthillier J, Gagne-Henley A, C-Gaudreault R, Morissette G. Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs. Toxicology and applied pharmacology,
2012. 259: 1-12
Turcotte V, Fortin S, Vevey F, Coulombe Y, Lacroix J, Cote MF, Masson JY, C-Gaudreault R. Synthesis, biological evaluation, and structure-activity relationships of novel substituted N-phenyl ureidobenzenesulfonate derivatives blocking cell cycle progression in S-phase and inducing DNA double-strand breaks. Journal of medicinal chemistry,
2012. 55: 6194-208
Fortin S, Wei L, Moreau E, Lacroix J, Cote MF, Petitclerc E, Kotra LP, Gaudreault RC. Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationships. European journal of medicinal chemistry,
2011. 46: 5327-42
Fortin S, Bouchon B, Chambon C, Lacroix J, Moreau E, Chezal JM, Degoul F, C-Gaudreault R. Characterization of the Covalent Binding of N-Phenyl-N'-(2-chloroethyl)ureas to {beta}-Tubulin: Importance of Glu198 in Microtubule Stability. The Journal of pharmacology and experimental therapeutics,
2011. 336: 460-7
Fortin S, Wei L, Moreau E, Lacroix J, Cote MF, Petitclerc E, Kotra LP, C-Gaudreault R. Design, synthesis, biological evaluation, and structure-activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4. Journal of medicinal chemistry,
2011. 54: 4559-80
Mounetou E, Miot-Noirault E, Gaudreault RC, Madelmont JC. N-4-iodophenyl-N'-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profiles. Investigational new drugs,
2010. 28: 124-31
Fortin S, Lacroix J, Cote MF, Moreau E, Petitclerc E, C-Gaudreault R. Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site. Biological procedures online,
2010. 12: 113-7
Fortin S, Moreau E, Lacroix J, Cote MF, Petitclerc E, C-Gaudreault R. Synthesis, antiproliferative activity evaluation and structure-activity relationships of novel aromatic urea and amide analogues of N-phenyl-N'-(2-chloroethyl)ureas. European journal of medicinal chemistry,
2010. 45: 2928-37
